Skip to content

Effectiveness of Repetitive Transcranial Magnetic Stimulation ( rTMS ) add-on therapy to Standard treatment in Major Depressive Disorder Patients with sexual dysfunction.

Effectiveness of Repetitive Transcranial Magnetic Stimulation ( rTMS ) add-on therapy to Standard treatment in Major Depressive Disorder Patients with sexual dysfunction in Sina Farshchian Hospital in Hamadan city

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160523028008N15
Enrollment
40
Registered
2021-06-08
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive episode. Major depressive episode

Interventions

Intervention 1: Intervention group: 10 session of 20 minute of trans cranial direct current stimulation by 2 ma. Intervention 2: Control group:10 sessions of 20 minutes with the same device that is i

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Consent to participate in the study. Patient with major depression (Montgomery-Asberg Depression Scale greater than 20) Not receive repeated transcranial magnetic stimulation and electroconvulsive therapy in the past two months Married men and women are sexually active and married between 18 and 60 years old Having sexual dysfunction

Exclusion criteria

Exclusion criteria: Patients at risk of suicide Patients with other psychiatric disorders such as bipolar disorder, psychosis, schizophrenia

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before and after 10 sessions of intervention. Method of measurement: Montgomery-Sberg Depression Scale and Hamilton Depression Inventory.;Sexual function. Timepoint: Before and after 10 sessions of intervention. Method of measurement: Female Sexual Function Questionnaire and Arizona Sexual Experience Scale.

Secondary

MeasureTime frame
Cognitive Assessment. Timepoint: Before and after 10 sessions of intervention. Method of measurement: Montreal Cognitive Function Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Keshavarzi

Hamedan University of Medical Sciences

drkeshavarzi@yahoo.com+98 81182851015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026